Flow Neuroscience

FDA-approved at-home brain stimulation treatment for depression

Malmö, Sweden · Founded 2016 · $23.8M raised

Medical Devices
Mental Healthcare
Headquarters
Malmö
Employees
11–50
Founded
2016
Business Model
B2C
Total Funding
$23.8M
Last Round
$13.0M Venture RoundOct 2025
Rounds
3

About

Flow Neuroscience develops the world's first FDA-approved at-home tDCS (transcranial direct current stimulation) treatment for Major Depressive Disorder. The Flow FL-100 headset is a non-invasive neuromodulation device used in combination with a behavioral therapy app, providing home-based treatment for patients with moderate to severe MDD. Backed by real-world evidence from over 40,000 users and multiple clinical trials, Flow has received medical certification across Europe and the UK, and FDA approval in the US.

Summary

Flow Neuroscience is a Medical Devices company based in Malmö, Sweden, founded in 2016. It has raised $23.8M in total across 3 rounds, most recently a $13.0M Venture Round round in Oct 2025. Investors include Khosla Ventures and Kirin Holdings.

Tech & App Stack

15 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Venture RoundVenture RoundOct 2025
$13.0M

Sign up to see all 3 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies